Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded revision label v3.4.2 and removed the prior operating-status notice (v3.4.1). No changes to the study details or outcomes.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now includes a government funding notice about operational status and a site revision update to v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now shows a glossary, a 'Last Update Submitted that Met QC Criteria' indicator, a 'No FEAR Act Data' notice, and a revision badge 'Revision: v3.4.0'. The previously displayed items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no impact on study details or navigation; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading. Specific Japanese sites (Aichi-ken, Chiba, Fukuoka, Hokkaido, Ishikawa-ken, Kanagawa, Osaka, Tokyo) were added, and the former per-location headings (Aichi-ken Locations, Chiba Locations, etc.) were removed.SummaryDifference0.8%

- Check92 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not be about the study. The revision label was updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.